Usana Health Sciences INC Form 4 insider transactions

USANA Health Sciences Director Ding Xia reported transactions involving common stock and restricted stock units.

USANA Health Sciences Director Gilbert A. Fuller reported the sale of 1,058 shares of common stock at $17 per share, reducing his direct beneficial ownership to zero.

USANA Health Sciences' Chief Information Officer, Peter Benedict, sold 4,553 shares of common stock for approximately $19.38 per share, reducing his direct beneficial ownership to zero.

USANA Health Sciences' Chief Operating Officer, Walter Noot, exercised restricted stock units and subsequently sold a portion of the acquired common stock.

USANA Health Sciences' Chief Commercial Officer, Brent Neidig, exercised restricted stock units and subsequently sold a portion of the acquired common stock to cover tax obligations.

USANA Health Sciences' Chief People Officer, Paul A. Jones, reported the acquisition of common stock through restricted stock unit conversion and the disposition of shares for tax purposes.

USANA Health Sciences CFO G Doug Iiekking exercised restricted stock units and sold a portion of the resulting common stock to cover tax obligations.

USANA Health Sciences' Chief Legal Officer, Joshua Foukas, converted 6,577 restricted stock units into common stock and subsequently sold 2,786 shares for tax purposes.

USANA Health Sciences CEO Kevin Guest reported the vesting of restricted stock units and subsequent sale of shares for tax purposes.

USANA Health Sciences Chief Information Officer Peter Benedict reported the acquisition of 3,906 common shares and the disposition of 1,174 shares for tax purposes.

USANA Health Sciences' Chief Scientific Officer, Kathryn Michelle Armstrong, exercised restricted stock units and sold a portion of the resulting common stock to cover tax obligations.

USANA Health Sciences' Chief Legal Officer, Joshua Foukas, reported selling common stock while simultaneously being granted a significant number of restricted stock units.

USANA Health Sciences' Chief Information Officer, Peter Benedict, was granted 21,775 restricted stock units, vesting over four years.

USANA Health Sciences Inc. granted 24,526 restricted stock units to Chief Scientific Officer Kathryn Michelle Armstrong, vesting over four years.

USANA Health Sciences Chief Operating Officer Walter Noot was granted 41,373 restricted stock units, vesting over four years.

USANA Health Sciences Chief Commercial Officer Brent Neidig received a grant of 37,610 restricted stock units, vesting over four years.

USANA Health Sciences' Chief People Officer, Paul A. Jones, was granted 25,622 restricted stock units, which will vest over four years.

USANA Health Sciences' Chief Financial Officer, G Doug Iekking, was granted 41,639 restricted stock units, vesting over four years.

USANA Health Sciences CEO and Executive Chairman, Kevin Guest, was granted 82,726 restricted stock units, aligning executive incentives with shareholder value.

USANA Health Sciences Chief Information Officer Peter Benedict reported the exercise of restricted stock units and subsequent sale of shares to cover tax obligations.

USANA Health Sciences Chief Operating Officer Walter Noot reported the vesting of restricted stock units and subsequent sales of shares to cover tax obligations.

USANA Health Sciences Chief Commercial Officer Brent Neidig reported the vesting of restricted stock units and subsequent tax-related sales of common stock over three days in February 2026.

USANA Health Sciences Chief People Officer Paul A. Jones reported the acquisition of common stock through RSU vesting and subsequent sale of shares for tax obligations.

USANA Health Sciences CFO G. Doug Iekking reported the vesting of Restricted Stock Units and subsequent sale of shares for tax obligations across three separate transactions in early February 2026.

USANA Health Sciences Chief Legal Officer Joshua Foukas increased his direct common stock ownership through RSU vesting and tax-related dispositions.

USANA Health Sciences CEO and Executive Chairman Kevin Guest converted restricted stock units into common stock and subsequently sold a portion to cover tax obligations over three days in February 2026.

USANA Health Sciences Director Timothy Wood reported the exercise of restricted stock units and subsequent sale of shares for tax purposes.

USANA Health Sciences Director Frederic J Winssinger converted 1,058 restricted stock units into common stock, increasing his direct beneficial ownership.

USANA Health Sciences Director J Scott Nixon converted 1,058 restricted stock units into common stock on January 22, 2026, increasing his direct beneficial ownership.

USANA Health Sciences Director Peggie Pelosi reported the acquisition of common stock from restricted stock units and a subsequent sale for tax withholding purposes.